Positions

Investigator On

  • Molecular Analysis and Lineage Tracing of Influenza-Specific, Lung-Resident Memory B Cells  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2020 - 2025
  • Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2020 - 2025
  • Tissue and Organ Specific Human B Cell Immunity  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2024
  • Tissue and Organ Specific Human B Cell Immunity - Project 1: Development and Maintenance of Human Glycan and Phospholipid Antibody Repertoires  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2024
  • Tissue and Organ Specific Human B Cell Immunity - Project 2: Characterization of Virus-Specific Human B Cell Subsets in Lymphoid and Non-Lymphoid Tissues  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2024
  • Tissue and Organ Specific Human B Cell Immunity - Core C: B Cell Receptor Repertoire, Cloning and Expression Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2024
  • Effects of Neonatal Microbial Exposure on Anti-Polysaccharide B Cell Development  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2017 - 2022
  • Assessing Flu-Specific Humoral Immunity in Human Lung after Ex Vivo Lung Perfusion  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2020 - 2022
  • Private Grant  awarded by ALTIMMUNE INC 2020 - 2021
  • Regulation of B Cell Clonal Diversity and Its Role in Disease  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2016 - 2021
  • Virus-Induced Cell Fate Decisions in Anti-Viral Immunity  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • Virus-induced Cell Fate Decisions in Anti-Viral Immunity - Administrative Supplement  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • Rheumatic Diseases Research Core Centers (P30)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2019
  • Natural Antibody Idiotopes as Biomarkers for Progression in The At-risk Setting for Type 1 Diabetes  awarded by Juvenile Diabetes Research Foundation International 2016 - 2018
  • Establishment and Metabolic Control of Influenza-Specific Lung-Resident Memory B Cells  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2015 - 2018
  • Antibody Induction by Group B Streptococcal Vaccines for Protection against Fungal Infections  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2016 - 2018
  • Analysis of Human and Mouse Antibodies to Beta Cell Antigens Bearing N-Acetyl Glucosamine Post-Translation Modifications and their Potential to Prevent Human Type 1 Diabetes  awarded by Juvenile Diabetes Research Foundation International 2014 - 2016
  • Identification and Analysis of the Physiological Ligand for TLT2  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2016
  • Education And Training

  • Doctor of Philosophy in Microbiology, University of Alabama at Birmingham 2007
  • Bachelor of Science or Mathematics in Biochemistry, University of Arkansas 2000
  • Full Name

  • Rodney King